Synta Pharmaceuticals Corp. (SNTA) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 36.7% since Dec 17.
This biopharmaceutical company has seen 1 positive revision in the past one month and its Zacks Consensus Estimate of a loss narrowed over the same period, suggesting that more solid trading could be ahead for Synta Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if Friday’s move higher can last.
Synta Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Investors interested in the med-biomed industry may consider stocks like Heska Corporation (HSKY), Gentium S.p.A (GENT) and Aastrom Biosciences, Inc. (ASTM) all holding a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >
SYNTA PHARMACEUTICALS INC (SNTA): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
AASTROM BIOSCIENCES INC (ASTM): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Investment & Company Information